ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 69,800
-400 (-0.57%)
Jul 21, 2026, 2:50 PM KST
ABL Bio Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ABL Bio stock has a consensus rating of "Buy" and an average price target of ₩257,500. The average 1-year stock price forecast is 268.91% higher than the current stock price, while the lowest is ₩230,000 (+229.51%) and the highest is ₩280,000 (+301.15%).
Price Target: ₩257,500 (+268.91%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ABL Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 4 | 5 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 5 | 5 | 5 | 4 |
Financial Forecast
Revenue This Year
110.90B
from 79.35B
Increased by 39.76%
Revenue Next Year
136.18B
from 110.90B
Increased by 22.79%
EPS This Year
5.25
from -734.00
EPS Next Year
214.25
from 5.25
Increased by 3,980.95%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.